<DOC>
	<DOC>NCT00831662</DOC>
	<brief_summary>The purpose of this study is to confirm the safety and efficacy of diquafosol tetrasodium ophthalmic solution, 2% vs. placebo, in subjects with dry eye disease.</brief_summary>
	<brief_title>The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Have best corrected visual acuity in both eyes of at least +0.7 or better Central corneal staining of 3 on the NEI scale If female, are nonpregnant or nonlactating Have a history of dry eye disease in both eyes Have normal lid anatomy Unable to withhold the use of contact lenses during the study or 2 weeks prior to the study Have had ocular surface surgery within the past year Are considered legally blind in one eye Have a serious medical condition which could confound study assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>